The oncogenic role of HK2 has been observed in other cancer conditions too, including gastric cancer [25], hepatocellular carcinoma [26–27], renal cell carcinoma [28], and in brain metastases of breast cancer [29–30]. Here, HK2 is linked to hepatocellular carcinoma.